Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 3 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2024 Filed Jun 11, 2024 17:13 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 301 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-072052 · ownership.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 301 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024. F5 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 17:13 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 301 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-072052 · ownership.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 21:13 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 454 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-072050 · ownership.xml · derivative · entry 2 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 454 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024. F3 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 21:13 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionCommon Stock | 454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-072050 · ownership.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 21:12 UTC |
SMITH J. JEFFERSONChief Research Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-072049 · ownership.xml · derivative · entry 4 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024. F5 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 21:12 UTC |
SMITH J. JEFFERSONChief Research Officer
|
Exercise / conversionCommon Stock | 163 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-072049 · ownership.xml · nonDerivative · entry 1 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:37 UTC |
Frankel StanleyDirector
|
GrantRestricted Stock Units · Derivative | 9,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-069940 · ownership.xml · derivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,826 Underlying: Common Stock · 9,826 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:37 UTC |
Germano Geno JDirector
|
GrantRestricted Stock Units · Derivative | 9,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-069938 · ownership.xml · derivative · entry 1 Germano Geno J · CIK 0001424383 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,826 Underlying: Common Stock · 9,826 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:37 UTC |
Brown MelindaDirector
|
GrantRestricted Stock Units · Derivative | 9,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-069942 · ownership.xml · derivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,826 Underlying: Common Stock · 9,826 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:37 UTC |
Buehler KevinDirector
|
GrantRestricted Stock Units · Derivative | 9,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-069941 · ownership.xml · derivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,826 Underlying: Common Stock · 9,826 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:36 UTC |
Pire Shari LisaDirector
|
GrantRestricted Stock Units · Derivative | 9,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-069936 · ownership.xml · derivative · entry 1 Pire Shari Lisa · CIK 0001892150 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,826 Underlying: Common Stock · 9,826 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:36 UTC |
Wadsworth Samuel C.Director
|
GrantRestricted Stock Units · Derivative | 9,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-069934 · ownership.xml · derivative · entry 1 Wadsworth Samuel C. · CIK 0001653056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,826 Underlying: Common Stock · 9,826 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 08, 2024 Filed May 8, 2024 20:25 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
GrantCommon Stock | 833 | $12.00 | $9,996.00 |
DisclosureSEC source: 0000950170-24-056138 · ownership.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,513 F1 · shares: Represents shares purchased through a definitive subscription agreement, pursuant to which the Issuer agreed to issue and sell shares of its common stock in a non-brokered private placement to certain members of its management. Read SEC document |
| May 08, 2024 Filed May 9, 2024 00:26 UTC |
Amoroso MichaelDirector · President and CEO
|
GrantCommon Stock | 8,334 | $12.00 | $100,008.00 |
DisclosureSEC source: 0000950170-24-056141 · ownership.xml · nonDerivative · entry 1 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,106 F1 · shares: Represents shares purchased through a definitive subscription agreement, pursuant to which the Issuer agreed to issue and sell shares of its common stock in a non-brokered private placement to certain members of its management. Read SEC document |
| May 08, 2024 Filed May 9, 2024 00:26 UTC |
Kelly John AlexanderChief Financial Officer
|
GrantCommon Stock | 8,334 | $12.00 | $100,008.00 |
DisclosureSEC source: 0000950170-24-056140 · ownership.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,014 F1 · shares: Represents shares purchased through a definitive subscription agreement, pursuant to which the Issuer agreed to issue and sell shares of its common stock in a non-brokered private placement to certain members of its management. Read SEC document |
| May 08, 2024 Filed May 9, 2024 00:25 UTC |
SMITH J. JEFFERSONChief Research Officer
|
GrantCommon Stock | 833 | $12.00 | $9,996.00 |
DisclosureSEC source: 0000950170-24-056139 · ownership.xml · nonDerivative · entry 1 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,446 F1 · shares: Represents shares purchased through a definitive subscription agreement, pursuant to which the Issuer agreed to issue and sell shares of its common stock in a non-brokered private placement to certain members of its management. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:25 UTC |
Frankel StanleyDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,202 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-054579 · ownership.xml · derivative · entry 2 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. F4 · derivative.expiration_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:25 UTC |
Frankel StanleyDirector
|
Exercise / conversionCommon Stock | 4,202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-054579 · ownership.xml · nonDerivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on May 4, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:25 UTC |
Germano Geno JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,202 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-054581 · ownership.xml · derivative · entry 2 Germano Geno J · CIK 0001424383 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. F4 · derivative.expiration_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:25 UTC |
Germano Geno JDirector
|
Exercise / conversionCommon Stock | 4,202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-054581 · ownership.xml · nonDerivative · entry 1 Germano Geno J · CIK 0001424383 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on May 4, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:26 UTC |
Pire Shari LisaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,202 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-054587 · ownership.xml · derivative · entry 2 Pire Shari Lisa · CIK 0001892150 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. F4 · derivative.expiration_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:26 UTC |
Pire Shari LisaDirector
|
Exercise / conversionCommon Stock | 4,202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-054587 · ownership.xml · nonDerivative · entry 1 Pire Shari Lisa · CIK 0001892150 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on May 4, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:26 UTC |
Buehler KevinDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,202 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-054586 · ownership.xml · derivative · entry 2 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. F4 · derivative.expiration_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:26 UTC |
Buehler KevinDirector
|
Exercise / conversionCommon Stock | 4,202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-054586 · ownership.xml · nonDerivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on May 4, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:26 UTC |
Wadsworth Samuel C.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 4,202 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-054584 · ownership.xml · derivative · entry 2 Wadsworth Samuel C. · CIK 0001653056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. F4 · derivative.expiration_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:26 UTC |
Wadsworth Samuel C.Director
|
Exercise / conversionCommon Stock | 4,202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-054584 · ownership.xml · nonDerivative · entry 1 Wadsworth Samuel C. · CIK 0001653056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on May 4, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:25 UTC |
Brown MelindaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,202 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-054576 · ownership.xml · derivative · entry 2 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024 F4 · derivative.expiration_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024 Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:25 UTC |
Brown MelindaDirector
|
Exercise / conversionCommon Stock | 4,202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-054576 · ownership.xml · nonDerivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on May 4, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| May 02, 2024 Filed May 3, 2024 18:33 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
SaleCommon Stock | 272 | $10.32 | $2,807.04 |
DisclosureSEC source: 0000950170-24-053115 · ownership.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,680 F4 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.11 to $10.53. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2024 Filed May 3, 2024 22:32 UTC |
SMITH J. JEFFERSONChief Research Officer
|
SaleCommon Stock | 154 | $10.32 | $1,589.28 |
DisclosureSEC source: 0000950170-24-053114 · ownership.xml · nonDerivative · entry 3 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,613 F4 · kind: The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.11 to $10.53. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2024 Filed May 3, 2024 22:30 UTC |
List AlanChief Medical Officer
|
SaleCommon Stock | 290 | $10.32 | $2,992.80 |
DisclosureSEC source: 0000950170-24-053113 · ownership.xml · nonDerivative · entry 2 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,488 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.11 to $10.53. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2024 Filed May 3, 2024 22:29 UTC |
Amoroso MichaelDirector · President and CEO
|
SaleCommon Stock | 1,526 | $10.32 | $15,748.32 |
DisclosureSEC source: 0000950170-24-053112 · ownership.xml · nonDerivative · entry 2 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,772 F4 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.11 to $10.53. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2024 Filed May 3, 2024 18:33 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
SaleRestricted Stock Units · Derivative | 918 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053115 · ownership.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 919 Underlying: Common Stock · 918 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F6 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| May 01, 2024 Filed May 3, 2024 18:33 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-053115 · ownership.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting of Restricted Stock Units ("RSUs") on March 3, 2024, and subsequent settlement of such vested RSUs on May 1, 2024. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:34 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,702 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053116 · ownership.xml · derivative · entry 3 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,702 Underlying: Common Stock · 1,702 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:34 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionCommon Stock | 1,702 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-053116 · ownership.xml · nonDerivative · entry 2 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents the partial vesting of Restricted Stock Units ("RSUs") on March 3, 2024, and subsequent settlement of such vested RSUs on May 1, 2024. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:32 UTC |
SMITH J. JEFFERSONChief Research Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 519 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053114 · ownership.xml · derivative · entry 5 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 519 Underlying: Common Stock · 519 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F6 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:32 UTC |
SMITH J. JEFFERSONChief Research Officer
|
Exercise / conversionCommon Stock | 519 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-053114 · ownership.xml · nonDerivative · entry 2 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting of Restricted Stock Units ("RSUs") on March 3, 2024, and subsequent settlement of such vested RSUs on May 1, 2024. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:30 UTC |
List AlanChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 982 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053113 · ownership.xml · derivative · entry 3 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 981 Underlying: Common Stock · 982 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F5 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:30 UTC |
List AlanChief Medical Officer
|
Exercise / conversionCommon Stock | 982 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-053113 · ownership.xml · nonDerivative · entry 1 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting of Restricted Stock Units ("RSUs") on March 3, 2024, and subsequent settlement of such vested RSUs on May 1, 2024. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:29 UTC |
Amoroso MichaelDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 3,417 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053112 · ownership.xml · derivative · entry 3 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,417 Underlying: Common Stock · 3,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F6 · derivative.expiration_date: On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:29 UTC |
Amoroso MichaelDirector · President and CEO
|
Exercise / conversionCommon Stock | 3,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-053112 · ownership.xml · nonDerivative · entry 1 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting of Restricted Stock Units ("RSUs") on March 21, 2024, and subsequent settlement of such vested RSUs on May 1, 2024. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| April 30, 2024 Filed Apr 30, 2024 22:34 UTC |
List AlanChief Medical Officer
|
SaleCommon Stock | 238 | $10.03 | $2,386.43 |
DisclosureSEC source: 0000950170-24-050769 · ownership.xml · nonDerivative · entry 2 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,796 F4 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.85 to $10.14. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 22:34 UTC |
List AlanChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 868 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-050769 · ownership.xml · derivative · entry 3 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 868 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F6 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 22:34 UTC |
List AlanChief Medical Officer
|
Exercise / conversionCommon Stock | 868 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-050769 · ownership.xml · nonDerivative · entry 1 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on April 26, 2024. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| April 18, 2024 Filed Apr 22, 2024 21:12 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
GrantRestricted Stock Units · Derivative | 25,277 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046597 · ownership.xml · derivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,277 Underlying: Common Stock · 25,277 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| April 18, 2024 Filed Apr 23, 2024 01:12 UTC |
SMITH J. JEFFERSONChief Research Officer
|
GrantRestricted Stock Units · Derivative | 31,343 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046599 · ownership.xml · derivative · entry 1 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,343 Underlying: Common Stock · 31,343 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| April 18, 2024 Filed Apr 23, 2024 01:12 UTC |
Amoroso MichaelDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 111,217 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046598 · ownership.xml · derivative · entry 1 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,217 Underlying: Common Stock · 111,217 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| April 18, 2024 Filed Apr 23, 2024 01:12 UTC |
Kelly John AlexanderChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 41,705 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046596 · ownership.xml · derivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,705 Underlying: Common Stock · 41,705 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 29, 2024 Filed May 3, 2024 22:34 UTC |
Kelly John AlexanderChief Financial Officer
|
GrantCommon Stock | 506 | $18.50 | $9,361.00 |
DisclosureSEC source: 0000950170-24-053116 · ownership.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,978 F1 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.